Patent: 6,333,169
✉ Email this page to a colleague
Summary for Patent: 6,333,169
Title: | HER2 extracellular domain |
Abstract: | An extracellular portion of the HER2 molecule, essentially free of transmembrane and cytoplasmic portions, which is antigenic in animals. Isolated DNA encoding the extracellular portion; an expression vector containing the isolated DNA; and a cell containing the expression vector. A process for producing the extracellular domain. A vaccine containing the extracellular domain. |
Inventor(s): | Hudziak; Robert Michael (San Francisco, CA), Shepard; H. Michael (San Francisco, CA), Ullrich; Axel (San Francisco, CA) |
Assignee: | |
Application Number: | 08/422,734 |
Patent Claims: | see list of patent claims |
Details for Patent 6,333,169
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Teknika Llc | TICE BCG | bcg live | For Injection | 102821 | 06/21/1989 | ⤷ Try a Trial | 2018-12-25 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |